ロード中...
GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
BACKGROUND/OBJECTIVES: Fasting dyslipidemia is commonly observed in insulin resistant states and mechanistically linked to hepatic overproduction of very low density lipoprotein (VLDL). Recently, the incretin hormone glucagon-like peptide-1 (GLP-1) has been implicated in ameliorating dyslipidemia as...
保存先:
| 出版年: | Mol Metab |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4264039/ https://ncbi.nlm.nih.gov/pubmed/25506548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2014.09.005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|